Publikationen
Prof. Dr. Matthias Heck
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2025 |
|
Gabler N., Kirchhoff S., Sauter A., Heck Matthias, Lorenzini T., Haller B., Weber W., Eiber M., Rauscher I..
18F-Flotufolastat PET/MR in suspicious prostate cancer: correlation with histopathological biopsy-results [Abstract].
https://doi.org/10.1055/s-0045-1804322
BibTeX | RIS | DOI |
|
Knipper Sophie, Lischewsk Flemming, Koehler Daniel, Eiber Matthias, van Leeuwen Fijs W. B., de Barros Hilda, Berrens Anne-Claire, Zuur Lotte, van Leeuwen Pim J., van der Poel Henk, Ambrosini Francesca, Falkenbach Fabian, Bud?us Lars, Steuber Thomas, Graefen Markus, Tennstedt Pierre, Gschwend Jürgen E., Horn Thomas, Heck Matthias M., Maurer Tobias.
Biochemical response of <0.1 ng/ml predicts therapy-free survival of prostate cancer patients following prostate-specific membrane antigen–targeted salvage surgery.
https://doi.org/10.1016/j.euo.2024.04.019
PDF | BibTeX | RIS | DOI |
|
Karimzadeh A., Fütterer C., Hansen K., Heck Matthias, Tauber R., D'Alessandria C., Weber W., Eiber M., Rauscher I..
External validation of baseline 68Ga-PSMA-11 PET-based prediction models using 18F-flotufolastat PET in patients with metastatic castration-resistant prostate cancer receiving 177Lu-labeled PSMA-targeted radioligand therapy [Abstract].
https://doi.org/10.1055/s-0045-1804353
BibTeX | RIS | DOI |
|
Gammel M., Olufs C., Brosch-Lenz J., Heck Matthias, Weber W., Eiber M., Rauscher I..
Insights into renal split function assessment via PSMA-ligand PET/CT [Abstract].
https://doi.org/10.1055/s-0045-1804376
BibTeX | RIS | DOI |
|
Schweiger Lilit, Maurer Tobias, Simon Ricarda, Horn Thomas, Heck Matthias M., Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
Pattern of failure in patients with biochemical recurrence after PSMA radioguided surgery.
https://doi.org/10.2967/jnumed.124.268151
BibTeX | RIS | DOI |
|
Karimzadeh Amir, Hansen Kimberley, Hasa Ergela, Haller Bernhard, Heck Matthias M., Tauber Robert, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer.
https://doi.org/10.1007/s00259-024-07003-2
PDF | BibTeX | RIS | DOI |
|
Falkenbach Fabian, Lischewski Flemming, Knipper Sophie, Koehler Daniel, Karakiewicz Pierre I., Tian Zhe, Saad Fred, Tilki Derya, Bud?us Lars, Steuber Thomas, Mandel Philipp, Wenzel Mike, Gschwend Jürgen E., Graefen Markus, Heck Matthias M., Maurer Tobias.
Prostate-specific membrane antigen–radioguided surgery in an EMBARK-like cohort of patients with oligorecurrent hormone-sensitive prostate cancer: delay in systemic treatment.
https://doi.org/10.1016/j.euf.2025.01.006
BibTeX | RIS | DOI |
|
2024 |
|
Karimzadeh Amir, Hecker Charlotte-Sophie, Heck Matthias M., Tauber Robert, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval.
https://doi.org/10.1186/s13550-024-01143-0
PDF | BibTeX | RIS | DOI |
|
2023 |
|
Karimzadeh Amir, Heck Matthias, Tauber Robert, Knorr Karina, Haller Bernhard, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
177 Lu-PSMA-I&T for treatment of metastatic castration-resistant prostate cancer: prognostic value of scintigraphic and clinical biomarkers.
https://doi.org/10.2967/jnumed.122.264402
BibTeX | RIS | DOI |
|
Knipper S., Lischewski F., Koehler D., Eiber M., Van Leeuwen F. W. B., De Barros H., Berrens A., Van Leeuwen P., Van Der Poel H., Falkenbach F., Bud?us L., Steuber T., Graefen M., Gschwend J. E., Tennstedt P., Horn T., Heck Matthias M., Maurer T..
A1122 - Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of patients treated with salvage lymph node dissection via PSMA-radioguided surgery [Abstract].
https://doi.org/10.1016/s0302-2838(23)01160-0
BibTeX | RIS | DOI |
|
Knipper Sophie, Mehdi Irai Mehrdad, Simon Ricarda, Koehler Daniel, Rauscher Isabel, Eiber Matthias, van Leeuwen Fijs W. B., van Leeuwen Pim, de Barros Hilda, van der Poel Henk, Bud?us Lars, Steuber Thomas, Graefen Markus, Tennstedt Pierre, Heck Matthias M., Horn Thomas, Maurer Tobias.
Cohort study of oligorecurrent prostate cancer patients: oncological outcomes of patients treated with salvage lymph node dissection via prostate-specific membrane antigen (PSMA) radioguided surgery.
https://doi.org/10.1016/j.eururo.2022.05.031
BibTeX | RIS | DOI |
|
Knipper S., Lischewski F., Koehler D., Eiber M., van Leeuwen F. W. B., de Barros H., Berrens A. C., van Leeuwen P., van der Poel H., Ambrosini F., Falkenbach F., Bud?us L., Steuber T., Graefen M., Tennstedt P., Gschwend J. E., Horn T., Heck Matthias M., Maurer T..
Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of prostate cancer patients treated with salvage lymph node dissection via PSMA-radioguided surgery [Abstract].
https://doi.org/10.1016/s2666-1683(23)01298-3
PDF | BibTeX | RIS | DOI |
|
Muehlematter Urs J., Schweiger Lilit, Ferraro Daniela A., Hermanns Thomas, Maurer Tobias, Heck Matthias M., Rupp Niels J., Eiber Matthias, Rauscher Isabel, Burger Irene A..
Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer.
https://doi.org/10.1007/s00259-023-06278-1
PDF | BibTeX | RIS | DOI |
|
Falkenbach Fabian, Ambrosini Francesca, Tennstedt Pierre, Eiber Matthias, Heck Matthias M., Preisser Felix, Graefen Markus, Bud?us Lars, Koehler Daniel, Knipper Sophie, Maurer Tobias.
EAU biochemical recurrence risk classification and PSA kinetics have no value for patient selection in PSMA-radioguided surgery (PSMA-RGS) for oligorecurrent prostate cancer.
https://doi.org/10.3390/cancers15205008
PDF | BibTeX | RIS | DOI |
|
Spohn Simon K. B., Draulans Cédric, Kishan Amar U., Spratt Daniel, Ross Ashley, Maurer Tobias, Tilki Derya, Berlin Alejandro, Blanchard Pierre, Collins Sean, Bronsert Peter, Chen Ronald, Dal Pra Alan, de Meerleer Gert, Eade Thomas, Haustermans Karin, H?lscher Tobias, H?cht Stefan, Ghadjar Pirus, Davicioni Elai, Heck Matthias M., Kerkmeijer Linda G. W., Kirste Simon, Tselis Nikolaos, Tran Phuoc T., Pinkawa Michael, Pommier Pascal, Deltas Constantinos, Schmidt-Hegemann Nina-Sophie, Wiegel Thomas, Zilli Thomas, Tree Alison C., Qiu Xuefeng, Murthy Vedang, Epstein Jonathan I., Graztke Christian, Gao Xin, Grosu Anca L., Kamran Sophia C., Zamboglou Constantinos.
Genomic classifiers in personalized prostate cancer radiation therapy approaches: a systematic review and future perspectives based on international consensus.
https://doi.org/10.1016/j.ijrobp.2022.12.038
PDF | BibTeX | RIS | DOI |
|
Groeben Christer, Boehm Katharina, Koch Rainer, Sonntag Ulrich, Nestler Tim, Struck Julian, Heck Matthias, Baunacke Martin, Uhlig Annemarie, Koelker Mara, Meyer Christian P., Becker Benedikt, Salem Johannes, Huber Johannes, Leitsmann Marianne.
Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-study.
https://doi.org/10.1007/s00345-022-04271-1
PDF | BibTeX | RIS | DOI |
|
Hekimsoy T., Heck Matthias M., Gschwend J. E., Schwamborn K., Eiber M., Weber W..
How many unnecessary prostate biopsies can be avoided by PSMA PET/MR? [Abstract].
https://doi.org/10.1055/s-0043-1766180
BibTeX | RIS | DOI |
|
Karimzadeh A., Soeiro P., Feuerecker B., Heck Matthias M., Tauber R., Knorr K., D'Alessandria C., Weber W., Eiber M., Rauscher I..
Improved quality of life in mCRPC patients receiving consecutive cycles of 177Lu-PSMA RLT [Abstract].
https://doi.org/10.1055/s-0043-1766217
BibTeX | RIS | DOI |
|
Karimzadeh Amir, Soeiro Paula, Feuerecker Benedikt, Hecker Charlotte-Sophie, Knorr Karina, Heck Matthias M., Tauber Robert, D'Alessandria Calogero, Weber Wolfgang, Eiber Matthias, Rauscher Isabel.
Improved quality of life in metastatic castration-resistant prostate cancer patients receiving consecutive cycles of 177Lu-PSMA I&T.
https://doi.org/10.2967/jnumed.123.265878
BibTeX | RIS | DOI |
|
Jahnen Matthias, Heck Matthias M..
Kommentar zu: Radikale Prostatektomie beim oligometastasierten Prostatakarzinom.
https://doi.org/10.1055/a-2060-4417
BibTeX | RIS | DOI |
|
Ambrosini Francesca, Falkenbach Fabian, Bud?us Lars, Graefen Markus, Koehler Daniel, Lischewski Flemming, Gschwend Juergen E., Heck Matthias M., Eiber Matthias, Knipper Sophie, Maurer Tobias.
Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer.
https://doi.org/10.23736/s2724-6051.23.05445-9
BibTeX | RIS | DOI |
|
Meagher Margaret F., Mir Maria C., Minervini Andrea, Kriegmair Maximilian, Heck Matthias M., Porpiglia Francesco, Van Bruwaene Siska, Linares Estefania, Hevia Vital, D'Anna Maurizio, Veccia Alessandro, Roussel Eduard, Claps Francesco, Palumbo Carlotta, Marchioni Michele, Afari Jonathan, Saitta Cesare, Liu Franklin, Rubio Jose, Campi Riccardo, Mari Andrea, Amiel Thomas, Checcucci Enrico, Musquera Mireia, Guruli Georgi, Pavan Nicola, Albersen Maarten, Antonelli Alessandro, Klatte Tobias, Autorino Riccardo, McKay Rana R., Derweesh Ithaar H..
Proposal for a two-tier re-classification of stage IV/M1 domain of renal cell carcinoma into M1 ("oligometastatic") and M2 ("polymetastatic") subdomains: analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC).
https://doi.org/10.3389/fonc.2023.1113246
PDF | BibTeX | RIS | DOI |
|
Lunger Lukas, Steinhelfer Lisa, Korn Philipp, Eiber Matthias, Maurer Tobias, Büchler Jakob, Horn Thomas, Gschwend Jürgen E., Heck Matthias M..
Prostate-specific membrane antigen–radioguided surgery facilitates pelvic lymph node dissection during radical prostatectomy for the treatment of locally advanced prostate cancer with regional lymph node metastases.
https://doi.org/10.1016/j.euo.2022.12.001
BibTeX | RIS | DOI |
|
Falkenbach Fabian, Knipper Sophie, Koehler Daniel, Ambrosini Francesca, Steuber Thomas, Graefen Markus, Bud?us Lars, Eiber Matthias, Lunger Lukas, Lischewski Flemming, Heck Matthias M., Maurer Tobias.
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.
https://doi.org/10.1007/s00345-023-04534-5
PDF | BibTeX | RIS | DOI |
|
Seifert Robert, Emmett Louise, Rowe Steven P., Herrmann Ken, Hadaschik Boris, Calais Jeremie, Giesel Frederik L., Reiter Robert, Maurer Tobias, Heck Matthias M., Gafita Andrei, Morris Michael J., Fanti Stefano, Weber Wolfgang A., Hope Thomas A., Hofman Michael S., Fendler Wolfgang Peter, Eiber Matthias.
Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE?V2).
https://doi.org/10.1016/j.eururo.2023.02.002
PDF | BibTeX | RIS | DOI |
|
Karimzadeh Amir, Heck Matthias M., Tauber Robert, Solaris Esteban, Nekolla Stephan, Knorr Karina, Haller Bernhard, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
The impact of PSMA PET–based eligibility criteria used in the prospective phase II TheraP trial in metastatic castration-resistant prostate cancer patients undergoing prostate-specific membrane antigen–targeted radioligand therapy.
https://doi.org/10.2967/jnumed.122.265346
BibTeX | RIS | DOI |
|
Lunger Lukas, Eiber Matthias, Heck Matthias M..
Theranostik.
https://doi.org/10.1007/978-3-662-67297-6_9
BibTeX | RIS | DOI |
|
Herms Elena, Weirich Gregor, Maurer Tobias, Wagenpfeil Stefan, Preuss Stephanie, Sauter Andreas, Heck Matthias, G?rtner Anita, Hauner Katharina, Autenrieth Michael, Kübler Hubert P., Holzapfel Konstantin, Schwarz-Boeger Ulrike, Heemann Uwe, Slotta-Huspenina Julia, Stock Konrad Friedrich.
Ultrasound-based "CEUS-Bosniak" classification for cystic renal lesions: an 8-year clinical experience.
https://doi.org/10.1007/s00345-022-04094-0
PDF | BibTeX | RIS | DOI |
|
2022 |
|
Zaum R., Hein S., Rauscher I., Weber W. A., Gafita A., Heck Matthias, Eiber M..
177-Lu-PSMA I&T therapy in patients with metastatic castration-resistant prostate cancer (mCRPC): evaluation of treatment response using PSMA-ligand PET/CT [Abstract].
https://doi.org/10.1055/s-0042-1746100
BibTeX | RIS | DOI |
|
Ilhan Harun, Kroenke Markus, Wurzer Alexander, Unterrainer Marcus, Heck Matthias, Belka Claus, Knorr Karina, Langbein Thomas, Rauscher Isabel, Schmidt-Hegemann Nina-Sophie, Schiller Kilian, Bartenstein Peter, Wester Hans-Jürgen, Eiber Matthias.
18F-rhPSMA-7 PET for the detection of biochemical recurrence of prostate cancer after curative-intent radiation therapy: a bicentric retrospective study.
https://doi.org/10.2967/jnumed.121.262861
BibTeX | RIS | DOI |
|
Herms E., Slotta-Huspenin J., G?rtner A., Preuss S., Hauner K., Heck Matthias, Autenrieth M., Maurer T., Kübler H., Holzapfel K., Sauter A., Schwarz-Boeger U., Wagenpfeil S., Heemann U., Stock K. F..
A0053 - Ultrasound based CEUS-Bosniak classification for cystic renal lesions: an 8-year clinical experience [Abstract].
https://doi.org/10.1016/s0302-2838(22)00141-5
BibTeX | RIS | DOI |
|
Groeben C., Boehm K., Sonntag U., Nestler T., Struck J., Heck Matthias, Baunacke M., Uhlig A., Koelker M., Meyer C. P., Becker B., Salem J., Huber J., Leitsmann M..
A0088 - Hospital rating websites play a minor role in hospital choice of uro-oncologic patients in Germany: results of the multicentric NAVIGATOR-study [Abstract].
https://doi.org/10.1016/s0302-2838(22)00176-2
BibTeX | RIS | DOI |
|
Knipper S., Mehdi Irai M., Simon R., K?hler D., Isabel R., Eiber M., Van Leeuwen F. W. B., Van Leeuwen P., Bud?us L., Steuber T., Graefen M., Tennstedt P., Heck Matthias, Horn T., Maurer T..
A0511 - Cohort study of oligorecurrent prostate cancer patients: oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery [Abstract].
https://doi.org/10.1016/s0302-2838(22)00594-2
BibTeX | RIS | DOI |
|
Maurer Tobias, Mehdi Irai Mehrdad, Rauscher Isabel, Simon Ricarda, Eiber Matthias, van Leeuwen Fijs W. B., van Leeuwen Pim, Budaeus Lars, Steuber Thomas, Graefen Markus, Tennstedt Pierre, Heck Matthias, Horn Thomas, Knipper Sophie.
Cohort study of oligorecurrent prostate cancer patients: oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery [Abstract].
https://doi.org/10.1200/jco.2022.40.6_suppl.106
BibTeX | RIS | DOI |
|
Babst Christa, Amiel Thomas, Maurer Tobias, Knipper Sophie, Lunger Lukas, Tauber Robert, Retz Margitta, Herkommer Kathleen, Eiber Matthias, von Amsberg Gunhild, Graefen Markus, Gschwend Juergen, Steuber Thomas, Heck Matthias.
Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer.
https://doi.org/10.1016/j.ajur.2021.04.003
PDF | BibTeX | RIS | DOI |
|
Karimzadeh A., Schweiger L., Wehrstedt R., Heck Matthias, Tauber R., Haller B., Gschwend J. E., Knorr K., D'Alessandria C., Weber W. A., Eiber M., Rauscher I..
Evaluation of the prognostic value of the PET eligibility criteria of the TheraP trial [Abstract].
https://doi.org/10.1055/s-0042-1745978
BibTeX | RIS | DOI |
|
Harke Nina N., Wagner Christian, Hermann Robert M., Hadaschik Boris A., Radtke Jan Philipp, Altay-Langguth Alev, Aufderklamm Stefan, Bach Christian, Becker-Schiebe Martina, Blana Andreas, Bruns Frank, Buse Stephan, Combs Stephanie E., Engels Christina L., Ezzibdeh Emad, Fiedler Marcel, Fischer Laura-Anna, Farzat Mahmoud, Frismann Alexander, Heck Matthias M., Henkenberens Christoph, Roesch Marie C., K?ding Christoph, Klautke Gunther, Krausewitz Philipp, Kuczyk Markus A., Leitsmann Conrad, Lettmaier Sebastian, Mahjoub Samy, Manseck Andreas, 威尼斯赌博游戏_威尼斯赌博app-【官网】enwald Daniel, Meyer Andreas, Micke Oliver, Moritz Rudolf, Ott Marcel, Peters Inga, Pokupic Sasa, Porres Daniel, Preisser Felix, Reichel Kathrin, Schneider Andreas, Schwentner Christian, Scobioala Sergiu, Truss Michael, Wegener Daniel, Wezel Felix, Willborn Kay, Witt J?rn H., Wittig Andrea, Wittlinger Michael, Wolff Hendrik A., Zimmermanns Volker, Christiansen Hans.
Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: a German survey on prostate cancer diagnosis and treatment.
https://doi.org/10.1371/journal.pone.0269827
PDF | BibTeX | RIS | DOI |
|
Meissner Valentin H., Rauscher Isabel, Schwamborn Kristina, Neumann Jan, Miller Gregor, Weber Wolfgang, Gschwend Jürgen E., Eiber Matthias, Heck Matthias M..
Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography.
https://doi.org/10.1016/j.eururo.2021.11.019
BibTeX | RIS | DOI |
|
Meissner Valentin H., Gschwend Jürgen E., Heck Matthias M..
Reply to Giancarlo Marra, Armando Stabile, Paolo Gontero, Francesco Montorsi, Alberto Briganti, and Giorgio Gandaglia’s Letter to the Editor re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup [Letter].
https://doi.org/10.1016/j.eururo.2022.01.039
BibTeX | RIS | DOI |
|
2021 |
|
Marchioni Michele, Cheaib Joseph G., Takagi Toshio, Pavan Nicola, Antonelli Alessandro, Everaerts Wourter, Heck Matthias, Rha Koon H., Mottrie Alexandre, Kaouk Jihad, Capitanio Umberto, Lima Estev?o, Veccia Alessandro, Crivellaro Simone, Linares Estefania, Celia Antonio, Porpiglia Francesco, Autorino Riccardo, Di Nicola Marta, Schips Luigi, Pierorazio Phillip M., Mir Maria Carmen.
Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis.
https://doi.org/10.23736/s2724-6051.20.03785-6
BibTeX | RIS | DOI |
|
Feuerecker Benedikt, Tauber Robert, Knorr Karina, Heck Matthias, Beheshti Ali, Seidl Christof, Bruchertseifer Frank, Pickhard Anja, Gafita Andrei, Kratochwil Clemens, Retz Margitta, Gschwend Jürgen E., Weber Wolfgang A., D'Alessandria Calogero, Morgenstern Alfred, Eiber Matthias.
Activity and adverse events of Actinium-225-PSMA-617 in advanced metastatic castration-resistant prostate cancer after failure of Lutetium-177-PSMA.
https://doi.org/10.1016/j.eururo.2020.11.013
BibTeX | RIS | DOI |
|
Marchioni Michele, Kriegmair Maximilian, Heck Matthias, Amiel Thomas, Porpiglia Francesco, Ceccucci Enrico, Campi Riccardo, Minervini Andrea, Mari Andrea, Van Bruwaene Siska, Linares Estefania, Hevia Vital, Musquera Mireia, D’Anna Mauricio, Derweesh Ithaar, Bradshaw Aaron, Autorino Riccardo, Guruli Georgi, Veccia Alessandro, Roussel Eduard, Albersen Maarten, Pavan Nicola, Claps Francesco, Antonelli Alessandro, Palumbo Carlotta, Klatte Tobias, Erdem Selcuk, Mir Maria Carmen.
Development of a novel risk score to select the optimal candidate for cytoreductive nephrectomy among patients with metastatic renal cell carcinoma: results from a multi-institutional registry (REMARCC).
https://doi.org/10.1016/j.euo.2020.12.010
BibTeX | RIS | DOI Published in collaboration with EAU-Young Academic Urologist Kidney Cancer Group. Please see publisher's website for further details. |
|
Lunger Lukas, Retz Margitta, Bandur Miriam, Souchay Marc, Vitzthum Elisabeth, J?ger Marion, Weirich Gregor, Schuster Tibor, Autenrieth Michael, Kübler Hubert, Maurer Tobias, Thalgott Mark, Herkommer Kathleen, Koll Florestan, Gschwend Jürgen E., Nawroth Roman, Heck Matthias M..
KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy.
https://doi.org/10.1038/s41391-020-00283-3
PDF | BibTeX | RIS | DOI |
|
Wuernschimmel Christoph, Amiel Thomas, Heck Matthias, Horn Thomas, Nguyen Noemi, Budaeus Lars, Knipper Sophie, Wenzel Mike, Rauscher Isabel, Eiber Matthias, Wang Hui, Maurer Tobias.
MP11-12 Regional lymph node metastasis on PSMA PET correlates with decreased BCR-free and therapy-free survival after radical prostatectomy [Abstract].
https://doi.org/10.1097/ju.0000000000001984.12
BibTeX | RIS | DOI |
|
Knipper Sophie, von Amsberg Gunhild, Stolzenbach Franziska, Steuber Thomas, Heck Matthias, Eiber Matthias, Berliner Christoph, Maurer Tobias.
Multimodal therapy in oligometastatic prostate cancer: a glimpse into the future? [Letter].
https://doi.org/10.1016/j.ajur.2020.05.001
PDF | BibTeX | RIS | DOI |
|
Lunger Lukas, Tauber Robert, Feuerecker Benedikt, Gschwend Jürgen E., Eiber Matthias, Heck Matthias M..
Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer.
https://doi.org/10.21037/tau-20-1135
PDF | BibTeX | RIS | DOI |
|
Maisch Phillipp, Lunger Lukas, Düwel Charlotte, Schmid Sebastian C., Horn Thomas, Gschwend Jürgen E., Sauter Andreas, Heck Matthias M..
Outcomes of palliative cystectomy in patients with locally advanced pT4 bladder cancer.
https://doi.org/10.1016/j.urolonc.2020.11.042
BibTeX | RIS | DOI |
|
Schiller Kilian, St?hrer Lucia, Düsberg Mathias, Borm Kai, Devecka Michal, Vogel Marco M. E., Tauber Robert, Heck Matthias M., Rauscher Isabel, Eiber Matthias, Gschwend Jürgen E., Duma Marciana Nona, Combs Stephanie E..
PSMA-PET/CT–based lymph node atlas for prostate cancer patients recurring after primary treatment: clinical implications for salvage radiation therapy.
https://doi.org/10.1016/j.euo.2020.04.004
BibTeX | RIS | DOI |
|
Karimzadeh A., Heck Matthias, Gschwend J. E., Weber W. A., Eiber M., Rauscher I..
PSMA-ligand uptake in posttherapeutic 177Lu-PSMA scintigraphy to assess response in patients with mCRPC [Abstract].
https://doi.org/10.1055/s-0041-1726861
BibTeX | RIS | DOI |
|
Amiel Thomas, Würnschimmel Christoph, Heck Matthias, Horn Thomas, Nguyen Noemi, Bud?us Lars, Knipper Sophie, Wenzel Mike, Rauscher Isabel, Eiber Matthias, Wang Hui, Maurer Tobias.
Regional lymph node metastasis on prostate specific membrane antigen positron emission tomography correlates with decreased biochemical recurrence-free and therapy-free survival after radical prostatectomy: a retrospective single-center single-arm observational study.
https://doi.org/10.1097/ju.0000000000001596
BibTeX | RIS | DOI |
|
Knipper Sophie, Ascalone Luigi, Ziegler Benjamin, Hohenhorst Jan L., Simon Ricarda, Berliner Christoph, van Leeuwen Fijs W. B., van der Poel Henk, Giesel Frederik, Graefen Markus, Eiber Matthias, Heck Matthias M., Horn Thomas, Maurer Tobias.
Salvage surgery in patients with local recurrence after radical prostatectomy.
https://doi.org/10.1016/j.eururo.2020.11.012
BibTeX | RIS | DOI |
|
Storz Enno, Heck Matthias.
Supportive Therapie und Begleitma?nahmen beim Einsatz von Onkologika.
https://doi.org/10.1007/978-3-662-61492-1_25
BibTeX | RIS | DOI |
|
2020 |
|
Mir Maresma M. C., Marchioni M., Campi R., Minervini A., Kriegmair M., Heck Matthias, Porpiglia F., Van Bruwaene S., Linares E., Hevia V., Musquera M., Derweesh I., Ghali F., Autorino R., Veccia A., Roussel E., Albertsen M., Pavan N., Antonellia A., Palumbo C., Capitanio U., Klatte T., Erdem S., Rubio-Briones J..
836 - Performance of a new risk assessment tool for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the targeted therapy era: REMARCC score [Abstract].
https://doi.org/10.1016/s2666-1683(20)33434-0
PDF | BibTeX | RIS | DOI Published on behalf of the YAU Renal Cancer Group. Please see publisher's website for further details. |
|
Roussel E., Campi R., Minervini A., Kriegmair M., Heck Matthias, Klatte T., Kara ?., Bertolo R., Erdem S., Capitanio U., Van Bruwaene S., Albersen M., Linares E., Antonelli A., Rubio J., Pavan N., Autorino R., Derweesh I., Musqueara M., Hevia V., Porpiglia F., Ouzaid I., Mir M. C..
837 - Predictors for perioperative complications in cytoreductive nephrectomy: analysis of the registry for metastatic RCC (REMARCC) [Abstract].
https://doi.org/10.1016/s2666-1683(20)33435-2
PDF | BibTeX | RIS | DOI Published on behalf of the Young Academic Urologists Renal Cancer Working Group. Please see publisher's website for further details. |
|
Campi R., Marchioni M., Roussel E., Capitanio U., Klatte T., Kriegmair M., Erdem S., Rubio-Briones J., Minervini A., Heck Matthias, Porpiglia F., Van Bruwaene S., Linares E., Hevia V., Musquera M., Derweesh I., Autorino R., Pavan N., Antonelli A., Palumbo C., Guruli G., Ghali F., Amiel T., Mir M..
840 - Minimally invasive versus open cytoreductive nephrectomy for primary metastatic renal cancer: a multi-institutional experience from the REMARCC registry [Abstract].
https://doi.org/10.1016/s2666-1683(20)33438-8
PDF | BibTeX | RIS | DOI Published on behalf of the YAU Renal Cancer Group. Please see publisher's website for further details. |
|
Marchioni M., Campi R., Minervini A., Klatte T., Kriegmair M., Erdem S., Capitanio U., Roussel E., Albertsen M., Heck Matthias, Porpiglia F., Van Bruwaene S., Linares E., Hevia V., Musquera M., Derweesh I., Autorino R., Pavan N., Antonelli A., Rubio-Briones J., Vecchia A., Checcucci E., Claps F., Mir M. C..
841 - The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: a retrospective analysis of a contemporary series [Abstract].
https://doi.org/10.1016/s2666-1683(20)33439-x
PDF | BibTeX | RIS | DOI Published on behalf of the YAU Renal Cancer Group. Please see publisher's website for further details. |
|
Meagher M. F., Mir M., Rubio J., Campi R., Minervini A., Mari A., Kriegmair M., Heck Matthias, Amiel T., Van Bruwaene S., Porpiglia F., Checcucci E., Linares E., Hevia V., Musquera M., Bradshaw A., Ghali F., Patel D., Autorino R., Rousel E., Pavan N., Antonelli A., Marchioni M., McKay R., Derweesh I..
842 - Proposal for a two-tier re-classification of stage IV/M1 renal cell carcinoma into M1 (oligometastatic) and M2 (polymetastatic) sub stages [Abstract].
https://doi.org/10.1016/s2666-1683(20)33440-6
PDF | BibTeX | RIS | DOI |
|
Meagher M. F., Mir M., Rubio J., Campi R., Minervini A., Kriegmair M., Heck Matthias, Van Bruwaene S., Linares E., Hevia V., Musquera M., D'Anna M., Ghali F., Patel D., Bradshaw A., Autorino R., Guruli G., Rousel E., Albertsen M., Pavan N., Claps F., Antonelli A., Palumbo C., Marchioni M., Derweesh I..
846 - Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: analysis of the REMARCC registry [Abstract].
https://doi.org/10.1016/s2666-1683(20)33444-3
PDF | BibTeX | RIS | DOI |
|
Gafita Andrei, Heck Matthias M., Rauscher Isabel, Tauber Robert, Cala Lisena, Franz Charlott, D'Alessandria Calogero, Retz Margitta, Weber Wolfgang A., Eiber Matthias.
Early prostate-specific antigen changes and clinical outcome following 177 Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
https://doi.org/10.2967/jnumed.119.240242
BibTeX | RIS | DOI |
|
Heck Matthias M., Gschwend Jürgen E..
Extended lymph node dissection for bladder cancer: do clinical trials rule out a benefit?.
https://doi.org/10.1016/j.euf.2019.08.003
BibTeX | RIS | DOI |
|
Meagher Margaret Frances, Autorino Ricardo, Kriegmair Maximilian, Mir Maria Carmen, Rubio Jose, Campi Riccardo, Mari Andrea, Heck Matthias, Porpiglia Francesco, Van Bruwaene Siska, Linares Espinos Estefania, Musquera Mireia, Ghali Fadi, Veccia Alessandro, Guruli Georgi, Rousel Eduard, Pavan Nicola, Antonelli Alessandro, Marchioni Michele, Derweesh Ithaar.
Impact of metastasectomy on progression free and overall survival in metastatic renal cell carcinoma: analysis of the REMARCC registry [Abstract].
https://doi.org/10.1200/jco.2020.38.6_suppl.753
BibTeX | RIS | DOI |
|
Mir M. Carmen, Marchioni Michele, Campi Riccardo, Minervini Andrea, Roussel Eduard, Albertsen Maarteen, Capitanio Umberto, Klatte Tobias, Maximilian Kriegmair, Erdem Selcuk, Rubio-Briones Jose, Heck Matthias, Porpiglia Francesco, Checcucci Enrico, Van Bruwaene Siska, Linares Estefania, Hevia Vital, Musquera Mireia, Musquera Mireia, D'Anna Mauricio, Derweesh Ithaar, Meagher Margaret F., Ghali Fadi, Autorino Riccardo, Vecchia Alessandro, Guruli Georgi, Pavan Nicola, Claps Francesco, Antonelli Alessandro, Palumbo Carlotta, Antonelli Alessandro.
MP14-07 Performance of a new risk assessment tool for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the targeted therapy era: REMARCC score [Abstract].
https://doi.org/10.1097/ju.0000000000000839.07
BibTeX | RIS | DOI |
|
Heck Matthias M., Koll Florestan J., Retz Margitta, Autenrieth Michael, Magg Kathrin, Lunger Lukas, Gschwend Jürgen E., Nawroth Roman.
Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection.
https://doi.org/10.1016/j.urolonc.2020.01.018
BibTeX | RIS | DOI |
|
Heck Matthias, Gschwend Jürgen E., Eiber Matthias.
PSMA-Theranostik beim Prostatakarzinom.
https://doi.org/10.1007/s00092-020-4210-x
BibTeX | RIS | DOI |
|
Roussel Eduard, Campi Riccardo, Larcher Alessandro, Verbiest Annelies, Antonelli Alessandro, Palumbo Carlotta, Derweesh Ithaar, Ghali Fady, Bradshaw Aaron, Meagher Margaret F., Heck Matthias, Amiel Thomas, Kriegmair Maximilian C., Rubio Jose, Musquera Mireia, D'Anna Maurizio, Autorino Riccardo, Guruli Georgi, Veccia Alessandro, Linares-Espinos Estefania, Van Bruwaene Siska, Hevia Vital, Porpiglia Francesco, Checcucci Enrico, Minervini Andrea, Mari Andrea, Pavan Nicola, Claps Francesco, Marchioni Michele, Capitanio Umberto, Beuselinck Benoit, Mir Maria C., Albersen Maarten.
Rates and predictors of perioperative complications in cytoreductive nephrectomy: analysis of the Registry for Metastatic Renal Cell Carcinoma.
https://doi.org/10.1016/j.euo.2020.04.006
BibTeX | RIS | DOI Published on behalf of the Young Academic Urologists Renal Cell Carcinoma Working Group. Please see publisher's website for further details. |
|
Marchioni M., Campi R., Minervini A., Klatte T., Kriegmair M. C., Erdem S., Capitanio U., Roussel E., Albertsen M., Heck Matthias, Porpiglia F., Van Bruwaene S., Linares E., Hevia V., Musquera M., Darweesh I., Autorino R., Pavan N., Antonelli A., Rubio-Briones J., Veccia A., Checcucci E., Claps F., Mir C..
SC177 - The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: a retrospective analysis of a contemporary series [Abstract].
https://doi.org/10.1016/s2666-1683(20)35499-9
PDF | BibTeX | RIS | DOI |
|
Heidegger Isabel, Brandt Maximilian P., Heck Matthias M..
Treatment of non-metastatic castration resistant prostate cancer in 2020: what is the best?.
https://doi.org/10.1016/j.urolonc.2019.11.007
BibTeX | RIS | DOI |
|
Maurer Tobias, Knipper Sophie, Heck Matthias M., Horn Thomas, Berliner Christoph, K?hler Daniel, Kr?nke Markus, Rauscher Isabel, Eiber Matthias.
[99mTc]Tc-PSMA-I&S: Anwendung zur Radioguided Surgery beim rezidivierten Prostatakarzinom.
https://doi.org/10.1055/a-1105-8039
BibTeX | RIS | DOI |
|
2019 |
|
Gafita Andrei, Rauscher Isabel, Retz Margitta, Knorr Karina, Heck Matthias, Wester Hans-Jürgen, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Tauber Robert.
Early experience of rechallenge 177Lu-PSMA radioligand therapy after an initial good response in patients with advanced prostate cancer.
https://doi.org/10.2967/jnumed.118.215715
BibTeX | RIS | DOI |
|
Gschwend Jürgen E., Heck Matthias M., Lehmann Jan, Rübben Herbert, Albers Peter, Wolff Johannes M., Frohneberg Detlef, de Geeter Patrick, Heidenreich Axel, K?lble Tilman, St?ckle Michael, Schn?ller Thomas, Stenzl Arnulf, Müller Markus, Truss Michael, Roth Stephan, Liehr Uwe-Bernd, Lei?ner Joachim, Bregenzer Thomas, Retz Margitta.
Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial.
https://doi.org/10.1016/j.eururo.2018.09.047
BibTeX | RIS | DOI |
|
Seitz A. K., Heck Matthias M., Kamer M. W., Grüllich C..
Molekulares Tumorboard Prostatakarzinom.
https://doi.org/10.1007/s00120-019-0933-2
BibTeX | RIS | DOI |
|
Gschwend Jürgen E., Heck Matthias.
Reply to Satoru Taguchi, Tohru Nakagawa, and Hiroshi Fukuhara's Letter to the Editor re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604–11 [Letter].
https://doi.org/10.1016/j.eururo.2019.04.032
BibTeX | RIS | DOI |
|
Horn Thomas, Kr?nke Markus, Rauscher Isabel, Haller Bernhard, Robu Stephanie, Wester Hans-Jürgen, Schottelius Margret, van Leeuwen Fijs W. B., van der Poel Henk G., Heck Matthias, Gschwend Jürgen E., Weber Wolfgang, Eiber Matthias, Maurer Tobias.
Single lesion on prostate-specific membrane antigen-ligand positron emission tomography and low prostate-specific antigen are prognostic factors for a favorable biochemical response to prostate-specific membrane antigen-targeted radioguided surgery in recurrent prostate cancer.
https://doi.org/10.1016/j.eururo.2019.03.045
BibTeX | RIS | DOI |
|
Heck Matthias M., Tauber Robert, Schwaiger Sebastian, Retz Margitta, D'Alessandria Calogero, Maurer Tobias, Gafita Andrei, Wester Hans-Jürgen, Gschwend Jürgen E., Weber Wolfgang A., Schwaiger Markus, Knorr Karina, Eiber Matthias.
Treatment outcome, toxicity, and predictive factors for radioligand therapy with 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer.
https://doi.org/10.1016/j.eururo.2018.11.016
BibTeX | RIS | DOI |
|
2018 |
|
Tauber R. L., Knorr K., Schwaiger S., Retz M., Maurer T., D'Alessandria C., Wester H.-J., Gschwend J., Weber W., Schwaiger M., Heck Matthias M., Eiber M..
Clinical experience with 100 consecutive patients treated with Lu-177-labeled PSMA-I&T radioligand therapy for metastatic castration-resistant prostate cancer: final analysis [Abstract].
https://doi.org/10.1093/annonc/mdy284.040
BibTeX | RIS | DOI |